Answers are grounded in this paper and cite their sources.
This study supports the need for a larger randomized controlled trial to evaluate the use of liraglutide (maximum dose 3.0 mg daily) in the management of obesity in people with severe mental illness.
No takes yet. Share an insight, caveat, or question.
Whicher et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: